CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • HLNE Dashboard
  • Financials
  • Filings
  • Transcripts
  • ETFs
  • Insider
  • Institutional
  • Shorts
  • News
  • Reddit
  • 8-K Filing

Hamilton Lane (HLNE) 8-KOther Events

Filed: 10 Sep 21, 4:06pm
Free signup for more
  • Track your favorite companies
  • Receive email alerts for new filings
  • Personalized dashboard of news and more
  • Access all data and search results
Sign up for free
Search this filing
?
Pre-defined:
Table of contents
    Filing tables
    Export all tables to Excel
    Filing exhibits
    SEC
    • 8-K Current report
    • 1.1 Underwriting agreement
    • 5.1 Legality opinion
    • Download Excel data file
    • View Excel data file
    HLNE similar filings
    • 26 May 22 Results of Operations and Financial Condition
    • 1 Feb 22 Results of Operations and Financial Condition
    • 2 Nov 21 Results of Operations and Financial Condition
    • 10 Sep 21 Other Events
    • 3 Sep 21 Submission of Matters to a Vote of Security Holders
    • 3 Aug 21 Results of Operations and Financial Condition
    • 22 Jun 21 Departure of Directors or Certain Officers
    Filing view
    Share this filing


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): September 7, 2021
    Hamilton Lane Incorporated
    (Exact Name of Registrant as specified in its charter)
    Delaware001-3802126-2482738
    (State or other jurisdiction of incorporation)(Commission File No.)(IRS Employer Identification No.)
    110 Washington Street,Suite 1300
    Conshohocken,PA19428
    (Address of principal executive offices)(Zip Code)
     (610) 934-2222 
    (Registrant’s telephone number, including area code)
    Not Applicable
    (Former Name or Former Address, if Changed Since Last Report)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐
     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Class A Common Stock, $0.001 par value per shareHLNEThe Nasdaq Stock Market LLC

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐



    Item 8.01. Other Events.

    On September 7, 2021, Hamilton Lane Incorporated (the “Company”), Hamilton Lane Advisors, L.L.C. (“HLA”) and certain selling stockholders entered into an underwriting agreement (the “Underwriting Agreement”) with Morgan Stanley & Co. LLC (the “Underwriter”) relating to the sale of 950,751 shares of Class A common stock, par value $0.001 per share (“Class A Common Stock”), of the Company at a price to the Underwriter of $84.15 per share in a registered public offering (the “Offering”). The Offering closed on September 10, 2021. The Company issued and sold 877,400 shares of Class A Common Stock, and the selling stockholders sold 73,351 shares, in the aggregate, of Class A Common Stock in the Offering. The Offering generated net proceeds for the Company of $73.8 million and net proceeds for the selling stockholders of $6.2 million. The Company intends to use the proceeds to settle, in cash, exchanges of membership units in HLA by certain of its members. The Company did not receive any proceeds from the sale of shares by the selling stockholders.

    The Underwriting Agreement contains customary representations and warranties of the parties, and indemnification and contribution provisions under which the Company, HLA and the selling stockholders have agreed to indemnify the Underwriter against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Pursuant to the Underwriting Agreement, the Company has agreed, subject to certain exceptions, not to sell or transfer any shares of Class A Common Stock or any securities convertible into or exercisable or exchangeable for Class A Common Stock for 75 days after September 7, 2021 without first obtaining the written consent of the Underwriter. The foregoing description is a summary and is qualified in its entirety by reference to the complete text of the Underwriting Agreement filed as Exhibit 1.1 hereto and incorporated herein by reference.

    The Offering was made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission (the “SEC”) on August 6, 2021 (File No. 333-258567), a base prospectus included as part of the registration statement, and a prospectus supplement, dated September 7, 2021, filed with the SEC pursuant to Rule 424(b) under the Securities Act. The Company is filing as Exhibit 5.1 to this Current Report on Form 8-K an opinion of its counsel, Faegre Drinker Biddle & Reath LLP, regarding certain Delaware law issues concerning the shares of Class A Common Stock sold in the Offering.

    Item 9.01. Financial Statements and Exhibits.

    (d) Exhibits
    Exhibit No.Description
    1.1
    Underwriting Agreement, dated September 7, 2021, among the Company, HLA, Morgan Stanley & Co. LLC and the selling stockholders referenced therein
    5.1
    Opinion of Faegre Drinker Biddle & Reath LLP, dated September 10, 2021
    23.1
    Consent of Faegre Drinker Biddle & Reath LLP (contained in Exhibit 5.1 above)
    104Cover Page Interactive Data File (embedded within the Inline XBRL document)




    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
    HAMILTON LANE INCORPORATED
    Date: September 10, 2021
    By: /s/ Lydia A. Gavalis
    Name:Lydia A. Gavalis
    Title:General Counsel and Secretary


    Finsight
    Resources
    • Knowledgebase
    • Log In
    • Register
    Company
    • About
    • Contact
    • Solutions
    Products
    • Deal Roadshow
    • DealVDR
    • Evercall
    • Finsight.com
    CapEdge
    • Earnings Calendar
    • Earnings Transcripts
    • EDGAR Filing Screener
    • IPO Calendar
    • Compliance
    • Privacy
    • Security
    • Terms
    AngelList LinkedIn